Kaletra ®
Showing 1 - 25 of >10,000
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
HIV Trial in Tulsa (Once daily)
Terminated
- HIV Infections
- Once daily
-
Tulsa, OklahomaOSU Internal Medicine Specialty Clinic
Dec 2, 2020
HIV Trial in Philadelphia (lopinavir/ritonavir plus maraviroc)
Terminated
- HIV Infections
- lopinavir/ritonavir plus maraviroc
-
Philadelphia, PennsylvaniaTemple General Internal Medicine
Oct 8, 2020
COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)
Terminated
- COVID-19
- SARS-CoV-2
- Ascorbic Acid
- +4 more
-
Chicago, Illinois
- +5 more
Jul 12, 2022
Pneumonia, Viral, Cytokine Storm Trial in Madrid, Valencia (radiation, device, drug)
Suspended
- Pneumonia, Viral
- Cytokine Storm
- Ultra-Low-dose radiotherapy
- +8 more
-
Madrid, Spain
- +1 more
Mar 14, 2022
COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)
Active, not recruiting
- COVID-19
- Lopinavir/Ritonavir 400 mg/100 mg
- Placebo
-
Aurora, Colorado
- +5 more
Aug 17, 2022
Coronavirus Infections, Post-exposure Prophylaxis Trial in Vancouver, Toronto (Lopinavir/ritonavir)
Active, not recruiting
- Coronavirus Infections
- Post-exposure Prophylaxis
-
Vancouver, British Columbia, Canada
- +3 more
Nov 29, 2021
Healthy Volunteers Trial in Austin (Pitavastatin (NK-104), Lopinavir/ritonavir)
Completed
- Healthy Volunteers
- Pitavastatin (NK-104)
- Lopinavir/ritonavir
-
Austin, Texas(unnamed)
Jun 9, 2021
Fixed Dose Combination of Lopinavir/Ritonavir in Human
Terminated
- HIV-1 Infection
-
Kazan, Tatarstan, Respublika, Russian Federation
- +9 more
Jul 1, 2021
Pneumonia, Viral Trial in Reus, Barcelona, Madrid (radiation, drug, device)
Recruiting
- Pneumonia, Viral
- Low-dose radiotherapy
- +7 more
-
Reus, Tarragona, Spain
- +2 more
Jul 29, 2021
HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)
Covid19, Pneumonia Trial in Bani Suwayf (Remdesivir, Hydroxychloroquine, Tocilizumab)
Recruiting
- Covid19
- Pneumonia
- Remdesivir
- +4 more
-
Banī Suwayf, EgyptBeni-suef University
Mar 15, 2021
Bioequivalence Trial in Akyurt, Sahinbey (Lopinavir/Ritonavir 200 mg/50 mg Film Tablet, Lopinavir/Ritonavir 200 mg/50 mg Film
Completed
- Bioequivalence
- Lopinavir/Ritonavir 200 mg/50 mg Film Tablet
- Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet
-
Akyurt, Ankara, Turkey
- +1 more
Nov 23, 2020
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Lopinavir/Ritonavir
- +2 more
- (no location specified)
Apr 22, 2021
COVID-19, Favipiravir, Kaletra Trial in Tehran (Favipiravir, Hydroxychloroquine, Lopinavir / Ritonavir)
Completed
- COVID-19
- +4 more
- Favipiravir
- +2 more
-
Tehran, Iran, Islamic Republic ofMohammad Sadegh Bagheri Baghdasht
Jun 12, 2020
HIV Trial in Nijmegen (Lopinavir/ritonavir)
Completed
- HIV Infections
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
Nov 9, 2020